Drug Type Small molecule drug |
Synonyms Compound 21y(Henan Normal University) |
Target |
Mechanism ERK1 modulators(Extracellular-signal-regulated kinase1 modulators), ERK2 modulators(Extracellular-signal-regulated kinase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CN | 14 Feb 2025 |